Latest News
Totally wins £16m in urgent care contract extensions
Healthcare services provider Totally reported on Friday that its urgent care division had been awarded several contract extensions, worth a total of about £16m.
Microsaic Systems signs support deal in China
Point-of-need mass spectrometry technology company Microsaic Systems has signed an agreement with Jiangsu Henzhihe Technologies Company (HZH), it announced on Friday, to support its relationship with its China distributor.
China says all crypto-related transactions are illegal
China's central bank said on Friday that all activities related to cryptocurrency transactions are illegal and must be banned.
Touchstone Exploration positive on completion of Royston-1
Touchstone Exploration has completed drilling the Royston-1 exploration well, it said on Friday, announcing that it encountered “substantial” hydrocarbon accumulations based on drilling and wireline log data.
Citi upgrades LondonMetric to 'buy'
Citi upgraded LondonMetric to ‘buy’ from ‘neutral’ on Friday, saying it remains confident of structural tailwinds for logistics, estimating a doubling of space requirement over around 10 years.
Europe midday: Shares fall on Evergrande woes, weak German Ifo
European stocks were lower on Friday as worries around debt-strapped property developer China Evergrande and a weak German business confidence survey hit sentiment.
London midday: Stocks a little weaker amid Evergrande uncertainty
London stocks were still a little weaker by midday on Friday amid ongoing concerns about Chinese property developer Evergrande.
Fusion Antibodies performing in line in year-to-date
Antibody discovery, engineering and supply company Fusion Antibodies said on Friday that revenue growth in the current year had been consistent year-on-year, and in line with its expectations.
JTC slumps as ShoreCap says it's time to take some profit
Fund management services provider JTC slumped on Friday after Shore Capital downgraded the stock to ‘sell’ from ‘hold’, saying it was time to take some profits after recent share price strength.
Mobile Tornado extends InTechnology loan facility for another year
Enterprise-level mobile communications technology company Mobile Tornado has extended its revolving loan facility agreement with InTechnology first entered into in September 2018, it announced on Friday.
Condor Gold upbeat on latest drilling results from Mestiza
Condor Gold announced on Friday that the first phase of infill drilling of 39 holes for 3371. 58 metres, using diamond core drilling, had been completed on the Mestiza open pit, with all assay results received.
Iofina turns in record first-half results
Iodine and specialty chemicals specialist Iofina reported “record” first half results on Friday, with revenue ahead 27% at $19. 9m.
Retail sales growth slows as driver shortage hits stock levels
Retail sales grew at the weakest pace since March in the 12 months to September, it was reported on Friday morning, while growth in orders placed with suppliers also slowed.
Asia report: Stocks mostly lower after Evergrande bond falls due
Most markets in Asia were lower on Friday, with Japan’s bourses a stark exception, as jitters around property giant China Evergrande continued.
Mexican restaurant chain Tortilla to float on AIM
Mexican restaurant chain Tortilla said on Friday that it’s planning to list on the London Stock Market and open up 45 new sites over the next five years.
Judges Scientific lifts interim dividend, sees FY ahead of expectations
Judges Scientific hiked its interim dividend by 15% on Friday as it reported a jump in profit and said it’s confident of exceeding market expectations for the full year as it recovers from the initial impact of the pandemic.
AstraZeneca reports latest positive results for 'Lynparza'
AstraZeneca said on Friday that positive high-level results from the ‘PROpel’ phase 3 trial showed ‘Lynparza’, or olaparib, in combination with abiraterone, demonstrated a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) versus standard-of-care abiraterone, as a first-line treatment for men with metastatic castration-resistant prostate cancer (mCRPC), with or without homologous recombination repair (HRR) gene mutations.
In The Style slides after profit warning
In The Style shares sank on Friday after the fashion brand warned that higher freight costs, disruption to the timing of shipments and increased customer returns were set to dent profits.
London open: Stocks edge lower as consumer confidence slumps
London stocks edged lower in early trade on Friday amid ongoing concerns about Chinese property developer Evergrande and after a survey showed that UK consumer confidence slumped in September.
CMA to investigate CVS acquisition of Quality Pet Care
The Competition and Markets Authority said on Friday that it has decided the investigate CVS Group's completed acquisition of Quality Pet Care, which trades asThe Vet.